Poinciana Advisors Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,814
Closed -$244K 131
2026
Q1
$244K Sell
2,814
-1,447
-34% -$139K 0.19% 100
2025
Q4
$409K Sell
4,261
-49
-1% -$4.76K 0.32% 52
2025
Q3
$410K Buy
4,310
+49
+1% +$4.5K 0.35% 48
2025
Q2
$371K Hold
4,261
0.33% 52
2025
Q1
$383K Sell
4,261
-13
-0.3% -$1.16K 0.4% 37
2024
Q4
$341K Buy
+4,274
New +$370K 0.35% 46

Other funds holding MDT

Poinciana Advisors Group's MDT Position: Q2 2026 in Review

Poinciana Advisors Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,814 shares — an estimated $244K sold.

Poinciana Advisors Group first reported a position in MDT in Q4 2024 and held it in 6 quarters. The position peaked at $410K in Q3 2025. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Poinciana Advisors Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Poinciana Advisors Group sold 2,814 Medtronic shares in Q2 2026, an estimated $244K.
  • Poinciana Advisors Group first reported a position in Medtronic in Q4 2024 and held it in 6 quarters.
  • Poinciana Advisors Group's Medtronic position peaked at $410K in Q3 2025.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Poinciana Advisors Group's 13F filing for Q2 2026, filed 28 Jul 2026.